Twelve patients (92.3%) had seizures at presentation, which is more frequent than in the DEM‐CHILD registry (70%).8 One third of patients had a focal epilepsy at onset, which has been rarely highlighted in CLN2 disease. Here, TPP1 is linked to focal epilepsy.